Exact Mass: 474.10161380000005

Exact Mass Matches: 474.10161380000005

Found 33 metabolites which its exact mass value is equals to given mass value 474.10161380000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-[({4-[4-({[1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

3-[({4-[4-({[1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

C23H23ClN2O5S (474.10161380000005)


   

3-[({4-[4-({[1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

3-[({4-[4-({[1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulphanyl]propanoic acid

C23H23ClN2O5S (474.10161380000005)


   

Rilmazafone

2-Amino-N-({1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-3-(dimethylcarbamoyl)-1H-1,2,4-triazol-5-yl}methyl)ethanimidate

C21H20Cl2N6O3 (474.097387)


   

Bacillisporin B

Bacillisporin B

C26H18O9 (474.0950778)


   

KS 619-1

KS 619-1

C26H18O9 (474.0950778)


   

Aspergiolide B

Aspergiolide B

C26H18O9 (474.0950778)


   

Schimperiquinone A

Schimperiquinone A

C30H18O6 (474.1103328)


   

Bisinaiquinone

Bisinaiquinone

C30H18O6 (474.1103328)


   

Hyperxanthone|Hypholomin A|Hypholomin-A|Hypholomine A

Hyperxanthone|Hypholomin A|Hypholomin-A|Hypholomine A

C26H18O9 (474.0950778)


   

Ki16425

3-[[[4-[4-[[[1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazoly]phenyl]methyl]thio]-propanoic acid

C23H23ClN2O5S (474.10161380000005)


   

Vandetanib

Vandetanib(ZD6474)

C22H24BrFN4O2 (474.10665559999995)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   

CDP-N-dimethylethanolamine

CDP-N-dimethylethanolamine

C13H24N4O11P2 (474.0916773999999)


   

Vandetanib (Zactima)

Vandetanib (Zactima)

C22H24BrFN4O2 (474.10665559999995)


   

Cys Cys Cys Phe

(2S)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C18H26N4O5S3 (474.10652660000005)


   

Cys Cys Phe Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C18H26N4O5S3 (474.10652660000005)


   

Cys Phe Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H26N4O5S3 (474.10652660000005)


   

Phe Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H26N4O5S3 (474.10652660000005)


   

HEXYLTRIPHENYLPHOSPHONIUM IODIDE

HEXYLTRIPHENYLPHOSPHONIUM IODIDE

C24H28IP (474.0973288)


   

Rilmazafone

Rilmazafone

C21H20Cl2N6O3 (474.097387)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

(4-chlorophenyl)methyl-triphenylphosphanium,tetrafluoroborate

(4-chlorophenyl)methyl-triphenylphosphanium,tetrafluoroborate

C25H21BClF4P (474.1098504)


   

Benzeneacetic acid, 4-chloro-a-[[2-[[[(1,1-dimethylethoxy)carbonyl]amino]iminomethyl]benzo[b]thien-6-yl]oxy]-, methyl ester

Benzeneacetic acid, 4-chloro-a-[[2-[[[(1,1-dimethylethoxy)carbonyl]amino]iminomethyl]benzo[b]thien-6-yl]oxy]-, methyl ester

C23H23ClN2O5S (474.10161380000005)


   

METHYL3,4-DI[[(4-METHYLPHENYL)SULFONYL]AMINO]BENZOATE

METHYL3,4-DI[[(4-METHYLPHENYL)SULFONYL]AMINO]BENZOATE

C22H22N2O6S2 (474.0919232)


   

3-Methyl-1-octyl-1H-imidazol-3-ium bis[(trifluoromethyl)sulfonyl]methanide

3-Methyl-1-octyl-1H-imidazol-3-ium bis[(trifluoromethyl)sulfonyl]methanide

C15H24F6N2O4S2 (474.10816159999996)


   

6-Chloro-2-oxo-4-methylchromen-7-yl 4-O-beta-D-xylopyranosyl-beta-D-xylopyranoside

6-Chloro-2-oxo-4-methylchromen-7-yl 4-O-beta-D-xylopyranosyl-beta-D-xylopyranoside

C20H23ClO11 (474.0928838)


   

N-(4-CHLORO-2-METHYLPHENYL)-2-(N-(3,4-DIMETHOXYPHENYL)PHENYLSULFONAMIDO)ACETAMIDE

N-(4-CHLORO-2-METHYLPHENYL)-2-(N-(3,4-DIMETHOXYPHENYL)PHENYLSULFONAMIDO)ACETAMIDE

C23H23ClN2O5S (474.10161380000005)


   

CDP-N,N-dimethylethanolamine

CDP-N,N-dimethylethanolamine

C13H24N4O11P2 (474.0916773999999)


   

5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide

5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide

C22H20ClFN4O3S (474.0928612)


   

CID 157010213

CID 157010213

C13H24N4O11P2+ (474.0916773999999)


   

3-[({4-[4-({[(1S)-1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

3-[({4-[4-({[(1S)-1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

C23H23ClN2O5S (474.10161380000005)


   

3-[({4-[4-({[(1R)-1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

3-[({4-[4-({[(1R)-1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid

C23H23ClN2O5S (474.10161380000005)


   

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)piperidine-3-carboxamide

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)piperidine-3-carboxamide

C21H22N4O5S2 (474.1031562)


   

methyl N-(tert-butoxycarbonyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]alaninate

methyl N-(tert-butoxycarbonyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]alaninate

C24H24Cl2N2O4 (474.1113044)


   

GluN2B-NMDAR antagonist-1

GluN2B-NMDAR antagonist-1

C26H23BrN2O2 (474.0942798)


GluN2B-NMDAR antagonist-1 is an orally active GluN2B-NMDAR antagonist. GluN2B-NMDAR antagonist-1 has neuroprotective activity. GluN2B-NMDAR antagonist-1 can be used for research of ischemic injury[1].